We collected information about Inozyme Pharma Inc Hours for you. Follow the liks to find out everything about Inozyme Pharma Inc Hours.
Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue, and skeleton that can be life-threatening and debilitating. Navigation. Company. Science.
https://www.nasdaq.com/market-activity/stocks/inzy/after-hours
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET).
https://www.barrons.com/market-data/stocks/inzy
Complete Inozyme Pharma Inc. stock information by Barron's. View real-time INZY stock price and news, along with industry-best analysis. ...
https://www.google.com/finance/quote/INZY:NASDAQ
Inozyme Pharma Inc. Follow. $15.81. After Hours: $15.81. (0.00%) 0.00. Closed: Aug 25, 4:11:57 PM GMT-4 · USD · NASDAQ · Disclaimer. No data.
https://investors.inozyme.com/node/6756/html
hours per response: 0.5: X: Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. ... Schlessinger Joseph (Last) (First) (Middle) C/O INOZYME PHARMA, INC. 321 SUMMER STREET, SUITE 400 (Street) BOSTON: MA: 02210 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Inozyme Pharma, Inc. [ INZY] 5 ...
https://www.inozyme.com/investor-relations?Subnav_Link_Tab=stock-information
Inozyme Pharma, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Inozyme Pharma, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Inozyme Pharma, Inc. or …
https://markets.businessinsider.com/stocks/inzy-stock
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) ... Inozyme Pharma Inc Registered Shs - - …
https://www.globenewswire.com/news-release/2021/11/15/2334153/0/en/Inozyme-Pharma-Announces-Dosing-of-First-Patient-in-First-in-Human-Clinical-Trial-of-INZ-701-in-Patients-with-ENPP1-Deficiency.html
Inozyme Pharma, Inc. (Nasdaq: INZY) is a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the ...
Searching for Inozyme Pharma Inc Hours?
You can just click the links above. The info is collected for you.
